The publisher regrets that the author affiliations as presented in the published article were incorrect. The correct list of authors and their proper affiliations appears above.
The publisher apologizes for any inconvenience caused.
Article Info
Publication History
Published online: January 09, 2021
Footnotes
Funding: None.
Conflicts of Interest: None.
Authorship: All authors had access to the data and a role in writing this manuscript.
Identification
Copyright
© 2021 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Cardiovascular Considerations for the Internist and Hospitalist in the COVID-19 EraThe American Journal of MedicineVol. 133Issue 11
- PreviewIt is clear that existing cardiovascular disease is a major risk factor for COVID-19 and related adverse outcomes. In addition to acute respiratory syndrome, a large cohort also develop myocardial or vascular dysfunction, in part from inflammation and renin angiotensin system activation with increased sympathetic outflow, cardiac arrhythmias, ischemia, heart failure, and thromboembolic complications that portend poor outcomes related to COVID-19. We summarize recent information for hospitalists and internists on the front line of this pandemic regarding its cardiovascular impacts and management and the need for cardiovascular consultation.
- Full-Text
- Preview
